Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Details for Australian Patent Application No. 2004274468 (hide)

Owner Vertex Pharmaceuticals, Incorporated

Inventors Perni, Robert P.; Pitlik, Janos; Cottrell, Kevin M.; Schairer, Wayne C.

Agent Cullen & Co

Pub. Number AU-B-2004274468

PCT Pub. Number WO2005/028502

Priority 60/504,405 18.09.03 US

Filing date 17 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 23 July 2009

International Classifications

A61K 38/07 (2006.01) Medicinal preparations containing peptides - Tetrapeptides

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/028502 Priority application(s): WO2005/028502

23 July 2009 Application Accepted

  Published as AU-B-2004274468

19 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004274471-Haloalkyl containing compounds as cysteine protease inhibitors

2004274459-Enhanced locomotive adhesion control